BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sartoris R, Rautou PE, Elkrief L, Pollorsi G, Durand F, Valla D, Spahr L, Terraz S, Soubrane O, Cauchy F, Vilgrain V, Ronot M. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension. Radiology 2018;289:698-707. [PMID: 30179109 DOI: 10.1148/radiol.2018181131] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Smith AD, Porter KK, Elkassem AA, Sanyal R, Lockhart ME. Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. American Journal of Roentgenology 2019;213:77-89. [DOI: 10.2214/ajr.19.21144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
2 Hai Y, Chong W, Eisenbrey JR, Forsberg F. Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension. Dig Dis Sci 2021. [PMID: 34275089 DOI: 10.1007/s10620-021-07168-y] [Reference Citation Analysis]
3 Vuille-Lessard É, Rodrigues SG, Berzigotti A. Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:253-89. [PMID: 33838850 DOI: 10.1016/j.cld.2021.01.005] [Reference Citation Analysis]
4 Sartoris R, Lazareth M, Nivolli A, Dioguardi Burgio M, Vilgrain V, Ronot M. CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria. Abdom Radiol 2020;45:2755-63. [DOI: 10.1007/s00261-020-02519-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kulkarni AV, Rabiee A, Mohanty A. Management of Portal Hypertension. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Smith AD. Enter the Era of Quantitative Liver CT. Radiology 2018;289:708-9. [DOI: 10.1148/radiol.2018181847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Kim TH, Jeong CW, Kim JE, Kim JW, Jo HG, Kim YR, Lee YH, Yoon KH. Assessment of Liver Fibrosis Stage Using Integrative Analysis of Hepatic Heterogeneity and Nodularity in Routine MRI with FIB-4 Index as Reference Standard. J Clin Med 2021;10:1697. [PMID: 33920804 DOI: 10.3390/jcm10081697] [Reference Citation Analysis]
8 Xu G, Li F, Mao Y. Portal pressure monitoring-state-of-the-art and future perspective. Ann Transl Med. 2019;7:583. [PMID: 31807564 DOI: 10.21037/atm.2019.09.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Sartoris R, Calandra A, Lee KJ, Gauss T, Vilgrain V, Ronot M. Quantification of Pancreas Surface Lobularity on CT: A Feasibility Study in the Normal Pancreas. Korean J Radiol 2021;22:1300-9. [PMID: 33938646 DOI: 10.3348/kjr.2020.1049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Reiberger T. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatol Commun 2021. [PMID: 34904404 DOI: 10.1002/hep4.1855] [Reference Citation Analysis]
11 Dana J, Venkatasamy A, Saviano A, Lupberger J, Hoshida Y, Vilgrain V, Nahon P, Reinhold C, Gallix B, Baumert TF. Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease. Hepatol Int 2022. [PMID: 35138551 DOI: 10.1007/s12072-022-10303-0] [Reference Citation Analysis]
12 Schattenberg JM, Emrich T. Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic? Eur Radiol 2022. [PMID: 35084517 DOI: 10.1007/s00330-021-08508-2] [Reference Citation Analysis]
13 Rana R, Wang S, Li J, Basnet S, Zheng L, Yang C. Diagnostic accuracy of non-invasive methods detecting clinically significant portal hypertension in liver cirrhosis: a systematic review and meta-analysis. Minerva Med 2020;111:266-80. [PMID: 31638361 DOI: 10.23736/S0026-4806.19.06143-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Giannelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP Rep 2020;2:100147. [PMID: 32885156 DOI: 10.1016/j.jhepr.2020.100147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Allaire M, Goumard C, Lim C, Le Cleach A, Wagner M, Scatton O. New frontiers in liver resection for hepatocellular carcinoma. JHEP Rep. 2020;2:100134. [PMID: 32695968 DOI: 10.1016/j.jhepr.2020.100134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Dioguardi Burgio M, Sartoris R, Beaufrere A, Grégory J, Guiu B, Guillot C, Rautou PE, Castera L, Bouattour M, Paradis V, Vilgrain V, Ronot M. Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD. Eur Radiol 2021. [PMID: 34533606 DOI: 10.1007/s00330-021-08261-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Hobeika C, Cauchy F, Sartoris R, Beaufrère A, Yoh T, Vilgrain V, Rautou PE, Paradis V, Bouattour M, Ronot M, Soubrane O. Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma. Br J Surg 2020;107:878-88. [PMID: 32118298 DOI: 10.1002/bjs.11511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
18 Seror M, Sartoris R, Hobeika C, Bouattour M, Paradis V, Rautou PE, Soubrane O, Vilgrain V, Cauchy F, Ronot M. Computed Tomography-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related Hepatocellular Carcinoma. Ann Surg Oncol 2021;28:405-16. [PMID: 32965614 DOI: 10.1245/s10434-020-09143-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., Clinical Practice Guideline Panel., Chair:., EASL Governing Board representative:., Panel members:. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol 2021;75:659-89. [PMID: 34166721 DOI: 10.1016/j.jhep.2021.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
20 Cho HJ, Choi J, Kim B, Ko J, Choi JI, Huh J, Lee JH, Kim JK. Combining hepatic surface nodularity and serum tests better predicts hepatic fibrosis stages in chronic liver disease. Abdom Radiol (NY) 2021;46:4189-99. [PMID: 33977353 DOI: 10.1007/s00261-021-03113-9] [Reference Citation Analysis]
21 Kim SW, Kim YR, Choi KH, Cho EY, Song JS, Kim JE, Kim TH, Lee YH, Yoon KH. Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI. AJR Am J Roentgenol 2020;215:624-30. [PMID: 32755157 DOI: 10.2214/AJR.19.22041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
22 Kennedy P, Bane O, Hectors SJ, Fischman A, Schiano T, Lewis S, Taouli B. Noninvasive imaging assessment of portal hypertension. Abdom Radiol 2020;45:3473-95. [DOI: 10.1007/s00261-020-02729-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Lin JY, Zhang CH, Zheng L, Li HJ, Zhu YM, Fan X, Li F, Xia Y, Huang MZ, Yang SH, Qi XL, Huo HZ, Chen HS, Lou XL, Luo M. Establishment and assessment of the hepatic venous pressure gradient using biofluid mechanics (HVPGBFM): protocol for a prospective, randomised, non-controlled, multicentre study. BMJ Open 2019;9:e028518. [PMID: 31796472 DOI: 10.1136/bmjopen-2018-028518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Sharma S, Chauhan A, Saraya A. Prediction of post TIPS hepatic encephalopathy: are we there yet? Hepatol Int 2021;15:1027. [PMID: 34117618 DOI: 10.1007/s12072-021-10216-4] [Reference Citation Analysis]
25 Elkassem AA, Allen BC, Lirette ST, Cox KL, Remer EM, Pickhardt PJ, Lubner MG, Sirlin CB, Dondlinger T, Schmainda M, Jacobus RB, Severino PE, Smith AD. Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients with Hepatitis C. AJR Am J Roentgenol 2021. [PMID: 34935403 DOI: 10.2214/AJR.21.27062] [Reference Citation Analysis]
26 Catucci D, Obmann VC, Berzigotti A, Gräni C, Guensch DP, Fischer K, Ebner L, Heverhagen JT, Christe A, Huber AT. Noninvasive assessment of clinically significant portal hypertension using ΔT1 of the liver and spleen and ECV of the spleen on routine Gd-EOB-DTPA liver MRI. Eur J Radiol 2021;144:109958. [PMID: 34571458 DOI: 10.1016/j.ejrad.2021.109958] [Reference Citation Analysis]
27 Liu Y, Tang T, Örmeci N, Huang Y, Wang J, Li X, Li Z, An W, Liu D, Zhang C, Liu C, Liu J, Liu C, Wang G, Mosconi C, Cappelli A, Bruno A, Akçalar S, Çelebioğlu E, Üstüner E, Bilgiç S, Ellik Z, Asiller ÖÖ, Li L, Zhang H, Kang N, Xu D, He R, Wang Y, Bu Y, Gu Y, Ju S, Golfieri R, Qi X. Noncontrast-enhanced MRI-based Noninvasive Score for Portal Hypertension (CHESS1802): An International Multicenter Study. J Clin Transl Hepatol 2021;9:818-27. [PMID: 34966645 DOI: 10.14218/JCTH.2021.00177] [Reference Citation Analysis]
28 Yoh T, Perrot A, Beaufrère A, Hobeika C, Sartoris R, Paradis V, Vilgrain V, Soubrane O, Cauchy F, Ronot M. Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy. Eur Radiol 2021;31:5830-9. [PMID: 33666699 DOI: 10.1007/s00330-020-07683-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 De Vos N, Sartoris R, Cauchy F, Rautou P, Vilgrain V, Ronot M. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT. Abdom Radiol 2020;45:365-72. [DOI: 10.1007/s00261-019-02355-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]